Effects of cytochrome P450 3A (CYP3A) and the drug transporters P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavir

Toxic lopinavir concentrations in an HIV-1 infected patient taking herbal medications

(2009) Carolien JP Beukel van den Bout-van den et al.   AIDS

Absence of Both Cytochrome P450 3A and P-glycoprotein Dramatically Increases Docetaxel Oral Bioavailability and Risk of Intestinal Toxicity

(2009) R. A.B. van Waterschoot et al.   CANCER RESEARCH

Drug Interactions between HIV Protease Inhibitors and Acid-Reducing Agents

(2008) Ronald W Falcon et al.   CLINICAL PHARMACOKINETICS

In Silico Methods for Unraveling the Mechanistic Complexities of Intestinal Absorption: Metabolism-Efflux Transport Interactions

(2008) L. X. Garmire et al.   DRUG METABOLISM AND DISPOSITION

Drug/Drug Interaction Between Lopinavir/Ritonavir and Rosuvastatin in Healthy Volunteers

(2008) Jennifer J Kiser et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Possible Antiretroviral Therapy–Warfarin Drug Interaction

(2008) Patricia Pecora Fulco et al.   PHARMACOTHERAPY